Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: Immunohistochemical and molecular biology study

Urology

Volumn 67, Issue 5, 2006, Pages 1111-1116

  Oelke, Matthias ^a   Hedlund, Petter ^b   Albrecht, Knut ^c   Ellinghaus, Peter ^d   Stief, Christian G ^e   Jonas, Udo ^c   Andersson, Karl Erik ^b   Ückert, Stefan ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d BAYER PHARMA AG   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE; FLUORESCEIN ISOTHIOCYANATE; ISOENZYME; MESSENGER RNA; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE V; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC AMP; CYCLIC GMP; PHOSPHODIESTERASE;

ADULT; ARTICLE; CLITORIS; CONTROLLED STUDY; CORPUS CAVERNOSUM; ENZYME LOCALIZATION; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCUBATION TIME; LASER MICROSCOPY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SMOOTH MUSCLE; TISSUE DISTRIBUTION; ADOLESCENT; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PENIS; PHYSIOLOGY; SEXUALITY; SIGNAL TRANSDUCTION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADOLESCENT; ADULT; CLITORIS; CYCLIC AMP; CYCLIC GMP; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; ISOENZYMES; MALE; PENIS; PHOSPHORIC DIESTER HYDROLASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEXUALITY; SIGNAL TRANSDUCTION;

EID: 33646836743     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.11.055     Document Type: Article

References (19)

1. Meston C.M., and Frohlich P.F. Update on female sexual function. Curr Opin Urol 11 (2001) 603-609
2. Levin R.J. The physiology of sexual function in women. Clin Obstet Gynecol 7 (1980) 213-252
3. Soderling S.H., and Beavo J.A. Regulation of cAMP and cGMP signaling. new phosphodiesterases and new functions. Curr Opin Cell Biol 12 (2000) 174-179
4. Taher A., Meyer M., Stief C.G., et al. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J Urol 15 (1997) 32-35
5. Stief C.G., Taher A., Meyer M., et al. Phosphodiesterase isoenzymes in human ureteral smooth muscle. identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro. Urol Int 55 (1995) 183-189
6. Truss M.C., Ückert S., Stief C.G., et al. Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle: I. Identification and characterization. Urol Res 24 (1996) 123-128
7. Ückert S., Küthe A., Jonas U., et al. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166 (2001) 2484-2490
8. D'Amati G., Di Giola C.R., Bologna M., et al. Type 5 phosphodiesterase expression in the human vagina. Urology 60 (2002) 191-195
9. Park K., Moreland R.B., Goldstein I., et al. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Comm 49 (1998) 612-617
10. Vemulapalli S., and Kurowski S. Sildenafil relaxes rabbit clitoral corpus cavernosum. Life Sci 67 (2000) 23-29
11. Müller T., Engels P., and Fozard J.P. Subtypes of type 4 cAMP phosphodiesterases. structure, regulation and selective inhibition. TIPS 17 (1996) 294-298
12. Toesca A., Stolfi V.M., and Cocchia D. Immunohistochemical study of the corpora cavernosa of the human clitoris. J Anat 188 (1996) 513-520
13. Burnett A.L., Calvin D.C., Silver R.I., et al. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 158 (1997) 75-78
14. Becker A.J., Stief C.G., Meyer M., et al. The effect of the specific phosphodiesterase 4 inhibitor rolipram on the ureteral peristalsis in vitro and in vivo. J Urol 160 (1998) 920-925
15. Truss M.C., Stief C.G., Ückert S., et al. Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction. from bench to bedside. World J Urol 19 (2001) 344-350
16. Berman J.R., Berman L., and Goldstein I. Female sexual dysfunction. incidence, pathophysiology, evaluation, and treatment options. Urology 54 (1999) 385-391
17. Maggi M., Filippi S., Ledda F., et al. Erectile dysfunction. from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol 43 (2000) 143-154
18. Berman J.R., Berman L.A., Lin H., et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 27 (2001) 411-420
19. Caruso S., Intelisano G., Lupo L., et al. Premenopausal women affected by sexual arousal disorder treated with sildenafil. a double-blind, crossover, placebo-controlled study. Br J Obstet Gynaecol 108 (2001) 623-628